Hypertrophic cardiomyopathy (HCM), the most common cause of sudden cardiac death in the young during exercise, exhibits cardiac pathophysiology, ischemia and impaired metabolic coronary flow regulation. Although the altered cardiac pathophysiology has been well documented, the impaired coronary vasomotor function has not been systematically characterized and the underlying mechanism responsible for this dysfunction has not been elucidated. Therefore, the long-term goals of this study are to understand the coronary vascular dysfunction associated with HCM and to elucidate the cellular and molecular mechanisms involved in this impairment. To achieve these goals, a recently developed transgenic mouse model resembling the cardiac pathophysiology observed in HCM patients will be used to test the central hypothesis that coronary microvascular reactivity to metabolic vasodilator adenosine is altered in HCM. Because adenosine receptors, vascular ATP-sensitive potassium (KATP) channels and endothelial release of nitric oxide (NO) are known to be involved in the coronary arteriolar dilation to adenosine and in metabolic regulation of coronary blood flow, we will examine whether the impairment of these pathways are responsible for the coronary microvascular dysfunction associated with HCM. More specifically, we will pursue the following specific aims to achieve these goals: (1) characterizing coronary vascular dysfunction in response to metabolic vasodilator adenosine. We will test the hypothesis that the downregulation of specific adenosine receptors, reduction of endothelial release of NO, and impairment of vascular KATP channels contribute to the vascular dysfunction associated with HCM; and (2) determining the role of vascular renin-angiotensin system in coronary vascular dysfunction. We will test the hypothesis that upregulation of renin-angiotensin system (e.g., renin, ACE, ANG-II and angiotensin receptors) is the underlying mechanism contributing to the impairment of vasodilation to adenosine via the inhibition of KATP channel function and the activation of oxidative stress. The results of these studies could enhance our understanding of coronary vascular dysfunction associated with HCM and may help to develop a therapeutic strategy to improve coronary function and to alleviate myocardial ischemia, which is known to aggravate the already impaired cardiac function in HCM.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Cardiovascular and Renal Study Section (CVB)
Program Officer
Varghese, Jamie
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Texas A&M University
Schools of Medicine
College Station
United States
Zip Code
Hein, Travis W; Qamirani, Erion; Ren, Yi et al. (2009) C-reactive protein impairs coronary arteriolar dilation to prostacyclin synthase activation: role of peroxynitrite. J Mol Cell Cardiol 47:196-202
Hein, Travis W; Singh, Uma; Vasquez-Vivar, Jeannette et al. (2009) Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo. Atherosclerosis 206:61-8
Thengchaisri, Naris; Shipley, Robert; Ren, Yi et al. (2007) Exercise training restores coronary arteriolar dilation to NOS activation distal to coronary artery occlusion: role of hydrogen peroxide. Arterioscler Thromb Vasc Biol 27:791-8
Thengchaisri, Naris; Hein, Travis W; Wang, Wei et al. (2006) Upregulation of arginase by H2O2 impairs endothelium-dependent nitric oxide-mediated dilation of coronary arterioles. Arterioscler Thromb Vasc Biol 26:2035-42
Zhang, Cuihua; Hein, Travis W; Wang, Wei et al. (2006) Activation of JNK and xanthine oxidase by TNF-alpha impairs nitric oxide-mediated dilation of coronary arterioles. J Mol Cell Cardiol 40:247-57
Qamirani, Erion; Razavi, Habib M; Wu, Xin et al. (2006) Sodium azide dilates coronary arterioles via activation of inward rectifier K+ channels and Na+-K+-ATPase. Am J Physiol Heart Circ Physiol 290:H1617-23
Qamirani, Erion; Ren, Yi; Kuo, Lih et al. (2005) C-reactive protein inhibits endothelium-dependent NO-mediated dilation in coronary arterioles by activating p38 kinase and NAD(P)H oxidase. Arterioscler Thromb Vasc Biol 25:995-1001
Hein, Travis W; Zhang, Cuihua; Wang, Wei et al. (2004) Heterogeneous beta2-adrenoceptor expression and dilation in coronary arterioles across the left ventricular wall. Circulation 110:2708-12